Cancer Research Versailles No Abst  Advances in Breast Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stavridi, E. S.
Right arrow Articles by Halazonetis, T. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stavridi, E. S.
Right arrow Articles by Halazonetis, T. D.
[Cancer Research 61, 7030-7033, October 1, 2001]
© 2001 American Association for Cancer Research


Advances in Brief

Substitutions That Compromise the Ionizing Radiation-induced Association of p53 with 14-3-3 Proteins Also Compromise the Ability of p53 to Induce Cell Cycle Arrest1

Elena S. Stavridi2, Nabil H. Chehab2, Asra Malikzay and Thanos D. Halazonetis3

The Wistar Institute [E. S. S., N. H. C., A. M., T. D. H.], Program in Biochemistry [N. H. C.], and Department of Pathology and Laboratory Medicine [T. D. H.], University of Pennsylvania, Philadelphia, Pennsylvania 19104-4268

Ionizing radiation (IR) induces an increase in the levels and activity of the p53 tumor suppressor protein. The increased activity is attributed to IR-induced posttranslational modifications, some of which regulate the interaction of p53 with other proteins. One of these modifications is dephosphorylation of Ser376, which leads to association of p53 with 14-3-3 proteins. To establish the significance of this interaction, we examined the function of mutant p53 proteins that do not interact with 14-3-3 proteins in vivo. These p53 mutants retained sequence-specific DNA binding activity. However, their ability to activate transcription of the endogenous p21/waf1/cip1 gene and to induce G1 arrest was compromised, suggesting that the dephosphorylation of Ser376 and the association of p53 with 14-3-3 proteins contribute to the activation of p53 in response to IR.




This article has been cited by other articles:


Home page
EndocrinologyHome page
S. Lu, K. A. Becker, M. J. Hagen, H. Yan, A. L. Roberts, L. A. Mathews, S. S. Schneider, H. T. Siegelmann, K. J. MacBeth, S. M. Tirrell, et al.
Transcriptional Responses to Estrogen and Progesterone in Mammary Gland Identify Networks Regulating p53 Activity
Endocrinology, October 1, 2008; 149(10): 4809 - 4820.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
Y. Pereg, S. Lam, A. Teunisse, S. Biton, E. Meulmeester, L. Mittelman, G. Buscemi, K. Okamoto, Y. Taya, Y. Shiloh, et al.
Differential Roles of ATM- and Chk2-Mediated Phosphorylations of Hdmx in Response to DNA Damage.
Mol. Cell. Biol., September 1, 2006; 26(18): 6819 - 6831.
[Abstract] [Full Text] [PDF]


Home page
Sci SignalHome page
D. Bridges and G. B. G. Moorhead
14-3-3 Proteins: A Number of Functions for a Numbered Protein
Sci. Signal., August 9, 2005; 2005(296): re10 - re10.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
A. Benzinger, N. Muster, H. B. Koch, J. R. Yates III, and H. Hermeking
Targeted Proteomic Analysis of 14-3-3{varsigma}, a p53 Effector Commonly Silenced in Cancer
Mol. Cell. Proteomics, June 1, 2005; 4(6): 785 - 795.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
J. M. A. Moreira, G. Ohlsson, F. E. Rank, and J. E. Celis
Down-regulation of the Tumor Suppressor Protein 14-3-3{sigma} Is a Sporadic Event in Cancer of the Breast
Mol. Cell. Proteomics, April 1, 2005; 4(4): 555 - 569.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. E. M. Meek, W. S. Lane, and H. Piwnica-Worms
Comprehensive Proteomic Analysis of Interphase and Mitotic 14-3-3-binding Proteins
J. Biol. Chem., July 30, 2004; 279(31): 32046 - 32054.
[Abstract] [Full Text] [PDF]


Home page
Sci SignalHome page
D. Bridges and G. B. G. Moorhead
14-3-3 Proteins: A Number of Functions for a Numbered Protein
Sci. Signal., July 20, 2004; 2004(242): re10 - re10.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
E. S. Stavridi and T. D. Halazonetis
p53 and stress in the ER
Genes & Dev., February 1, 2004; 18(3): 241 - 244.
[Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
H.-Y. Yang, Y.-Y. Wen, C.-H. Chen, G. Lozano, and M.-H. Lee
14-3-3{sigma} Positively Regulates p53 and Suppresses Tumor Growth
Mol. Cell. Biol., October 15, 2003; 23(20): 7096 - 7107.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.